New Diabetes Drugs May Also Improve Kidney Health

The renal protective effects seen with the SGLT2 inhibitor canogliflizin may be independent of glycemic control, suggest authors of a new post-hoc analysis.
Source: ConsultantLive - Category: Internal Medicine Authors: Source Type: news